11/20/2018
New Vaccine May Protect People with Celiac Disease from Gluten Exposure
Celiac Disease Foundation quoted in Healthline article covering the Nexvax2 therapeutic vaccine candidate.
Continue ReadingResearch News
11/14/2018
How the Gluten-Free Craze Affects Celiac Patients
How the Gluten-Free Craze Affects Celiac Patients
Continue Reading11/7/2018
Celiac Disease Foundation Attends PCORI 2018 Annual Meeting and Advocacy Day
Celiac Disease Foundation Attends PCORI 2018 Annual Meeting and Advocacy Day
Continue Reading10/16/2018
iCureCeliac® Study Presented at Digestive Disease Week 2018
In a Medscape Gastroenterology article covering Digestive Disease Week (DDW) 2018, William Balistreri, MD, reported on the studies presented that addressed reliable, cost-effective celiac disease detection. One of the studies…
Continue Reading10/16/2018
Prevalence of Epilepsy in Celiac and Gluten-Sensitive Patients
Previous studies have found celiac disease to be associated with several neurological complications. In a new study, researchers reviewed the available literature to determine the prevalence of epilepsy in patients…
Continue ReadingRecent Posts
- The 2024 Nobel Prize in Chemistry goes to a leading celiac disease researcher
- Biomarkers May Help Predict Celiac Disease in Patients with Type 1 Diabetes
- New Wheat Discovery Could Reduce the Impact of Celiac Disease
- Adriana Carrieri's Rising Villus Award for Celiac College Research
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Research News
- Research Press
- Trending Topics
Marilyn's Message
9/26/2024
Read more2024 International Celiac Disease Symposium Recap
Last month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...